AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 11(4), 1962, pp. 562-569
Copyright © 1962 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sweet, B. H.
Right arrow Articles by Tamiya, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sweet, B. H.
Right arrow Articles by Tamiya, T.

Immunological Studies with Group B Arthropod-Borne Viruses

II. Effect of Prior Infection with Japanese Encephalitis Virus on the Viremia in Human Subjects Following Administration of 17D Yellow Fever Vaccine*

Benjamin H. Sweet{dagger} AND Charles L. Wisseman, Jr.
Department of Microbiology, University of Maryland Medical School, Baltimore, Maryland

Masami Kitaoka AND Takeo Tamiya
National Institute of Health, Tokyo, Japan

The incidence of viremia following vaccination with the 17D strain of yellow fever virus did not differ appreciably in a group of human subjects possessing prevaccination Japanese encephalitis neutralizing antibodies as a result of previous inapparent natural infection from the incidence of viremia in control groups possessing no prevaccination Group B arbor virus antibodies. There may have been a slight diminution in the level of circulating virus among the subjects with prevaccination JE neutralizing antibodies as compared with the level in the control groups; however, the number of uncontrolled factors which may have influenced these measurements precludes a firm conclusion on this matter.


* This work was carried out under Contract Number DA-49-007-MD-660 with the Office of the Surgeon General, Department of the Army, U.S. Department of Defense under the auspices of the Commission on Immunization of the Armed Forces Epidemiological Board.


{dagger} Present address: Merck Institute for Research, West Point, Pennsylvania.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
N. KANESA-THASAN, W. SUN, G. V. LUDWIG, C. ROSSI, J. R. PUTNAK, J. A. MANGIAFICO, B. L. INNIS, and R. EDELMAN
ATYPICAL ANTIBODY RESPONSES IN DENGUE VACCINE RECIPIENTS
Am J Trop Med Hyg, December 1, 2003; 69(90060): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Guirakhoo, J. Arroyo, K. V. Pugachev, C. Miller, Z.-X. Zhang, R. Weltzin, K. Georgakopoulos, J. Catalan, S. Ocran, K. Soike, et al.
Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine
J. Virol., August 15, 2001; 75(16): 7290 - 7304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1962 by the American Society of Tropical Medicine and Hygiene.